The Use of GnRH Agonists in the Medical Therapy of Endometriosis in the Woman with Pain
review
OA: closed
CC0
⤵ 4 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
This paper reviews the medical therapy of endometriosis pain using gonadotropin-releasing hormone (GnRH) agonists.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cited by (4)
- GnRH analogs: Options for endometriosis-associated pain treatment 2006
- Treatment of endometriosis with a decreasing dosage of a gonadotropin-releasing hormone agonist (nafarelin): a pilot study with low-dose agonist therapy (“draw-back” therapy) 2000
- The Effect of Gonadotropin-Releasing Hormone Agonist on Type I Collagen C-Telopeptide and N-Telopeptide: the Predictive Value of Biochemical Markers of Bone Turnover 1998
- GnRH agonist and antagonist: Options for endometriosis pain treatment 2006
Cited by (4)
- GnRH agonist and antagonist: Options for endometriosis pain treatment 2006
- GnRH analogs: Options for endometriosis-associated pain treatment 2006
- Treatment of endometriosis with a decreasing dosage of a gonadotropin-releasing hormone agonist (nafarelin): a pilot study with low-dose agonist therapy (“draw-back” therapy) 2000
- The Effect of Gonadotropin-Releasing Hormone Agonist on Type I Collagen C-Telopeptide and N-Telopeptide: the Predictive Value of Biochemical Markers of Bone Turnover 1998
Source provenance
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- unpaywall
- last seen: 2026-08-18T06:27:49.008893+00:00
License: CC0
· commercial use OK